AML: Genetic Testing Unlocks Hope
AML is a deadly form of blood cancer, but advancements in treatment options have improved survival rates, particularly for children.
Source: medscape.com
Page 49 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genentech Today - Breaking & Trending Today
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript February 28, 2024 Kiniksa Pharmaceuticals, Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Fourth Quarter and Full […]
Source: yahoo.com
FDA Approves Omalizumab for Multiple Food Allergy
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.
Source: medscape.com
Natera, Inc. (NASDAQ:NTRA) Q4 2023 Earnings Call Transcript
Natera, Inc. (NASDAQ:NTRA) Q4 2023 Earnings Call Transcript February 28, 2024 Natera, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator […]
Source: yahoo.com
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2023 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2023 Earnings Call Transcript February 28, 2024 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $-0.16. NAUT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for […]
Source: yahoo.com